Some stretch the period from seven days, initially to ten, then slowly increase the period, lowering their dependence on the GLP-1 medication
In analysis of TTO based on parameter distributions and the valid cases, the median TTOs (Interquartile range) for SSIBs associated with semaglutide, liraglutide, dulaglutide, and exenatide were 15.5 (0.524.25, n = 18), 9.5 (0.561.5, n = 19), 35.5 (6.560.5, n = 11), and 2.5 (1.5169.5, n = 4) days, respectively (albiglutide was not included in the TTO analysis due to insufficient data)
Einige Anbieter vertreiben ausserdem neue Peptid-Wirkstoffe, deren Wirksamkeit noch nicht klinisch belegt ist
And always wipe the stopper with an alcohol swab before each puncture